Intensifying Continuous Production of Gag-HA VLPs at High Cell Density Using Stable Insect Cells Adapted to Low Culture Temperature.
alternating tangential flow filtration
high cell density
influenza virus-like particles
insect cells
perfusion
tangential flow filtration
Journal
Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
04
2022
accepted:
18
05
2022
entrez:
18
7
2022
pubmed:
19
7
2022
medline:
19
7
2022
Statut:
epublish
Résumé
Protein production processes based on stable insect cell lines require intensification to be competitive with the insect cell-baculovirus expression vector system (IC-BEVS). High cell density (HCD) cultures operate continuously, capable of maintaining specific production rates for extended periods of time which may lead to significant improvements in production yields. However, setting up such processes is challenging (e.g., selection of cell retention device and optimization of dilution rate), often demanding the manipulation of large volumes of culture medium with associated high cost. In this study, we developed a process for continuous production of Gag virus-like particles (VLP) pseudotyped with a model membrane protein (influenza hemagglutinin, HA) at HCD using stable insect cells adapted to low culture temperature. The impact of the cell retention device (ATF vs. TFF) and cell-specific perfusion rate (CSPR) on cell growth and protein expression kinetics was evaluated. Continuous production of Gag-HA VLPs was possible using both retention devices and CSPR of 0.04 nL/cell.d; TFF induces higher cell lysis when compared to ATF at later stages of the process (k
Identifiants
pubmed: 35845394
doi: 10.3389/fbioe.2022.917746
pii: 917746
pmc: PMC9277389
doi:
Types de publication
Journal Article
Langues
eng
Pagination
917746Informations de copyright
Copyright © 2022 Fernandes, Correia, Alves and Roldão.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
BMJ. 2021 Feb 1;372:n296
pubmed: 33526412
Vaccine. 2005 Dec 30;23(50):5751-9
pubmed: 16143432
Biotechnol Bioeng. 2021 Jul;118(7):2536-2547
pubmed: 33764532
Biotechnol Adv. 2018 Jul - Aug;36(4):1328-1340
pubmed: 29738813
Appl Microbiol Biotechnol. 2016 Mar;100(5):2121-32
pubmed: 26758296
J Nanobiotechnology. 2021 Feb 25;19(1):59
pubmed: 33632278
Vaccines (Basel). 2020 Oct 07;8(4):
pubmed: 33036359
Biotechnol Bioeng. 2020 Oct;117(10):3040-3052
pubmed: 32568408
J Biotechnol. 2021 Jul 20;335:65-75
pubmed: 34090946
Virology. 2009 Jan 5;383(1):12-21
pubmed: 18986663
Virology. 2016 Jan;487:163-71
pubmed: 26529299
Clin Vaccine Immunol. 2010 Oct;17(10):1560-6
pubmed: 20668137
J Biotechnol. 2017 Mar 20;246:52-60
pubmed: 28159614
Free Radic Biol Med. 2008 Feb 15;44(4):671-81
pubmed: 18036351
PLoS Negl Trop Dis. 2013;7(3):e2124
pubmed: 23516657
FEBS Lett. 2004 Oct 8;576(1-2):174-8
pubmed: 15474033
Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3459-64
pubmed: 15699356
Biotechnol Bioeng. 2012 Dec;109(12):3018-29
pubmed: 22729761
Expert Rev Vaccines. 2013 Feb;12(2):225-36
pubmed: 23414412
BMC Biotechnol. 2010 Mar 31;10:30
pubmed: 20356379
Expert Rev Vaccines. 2010 Oct;9(10):1149-76
pubmed: 20923267
Mol Biotechnol. 2010 Jul;45(3):226-34
pubmed: 20300881
iScience. 2020 Oct 07;23(11):101653
pubmed: 33145483
Cytotechnology. 1996 Jan;22(1-3):225-37
pubmed: 22358933
Trends Mol Med. 2010 Jul;16(7):313-20
pubmed: 20570562
Vaccine. 2018 May 24;36(22):3112-3123
pubmed: 28291648
Biotechnol Bioeng. 2003 Jun 30;82(7):751-65
pubmed: 12701141
Biotechnol Prog. 2017 Jul;33(4):891-901
pubmed: 28371394
Biotechnol Bioeng. 2017 Jul;114(7):1438-1447
pubmed: 28128436
J Biotechnol. 2020 Jan 10;307:139-147
pubmed: 31697977
Adv Biochem Eng Biotechnol. 2006;101:75-98
pubmed: 16989258
Appl Environ Microbiol. 2006 Jun;72(6):4001-6
pubmed: 16751508
Biotechnol Bioeng. 2003 Jan 20;81(2):211-20
pubmed: 12451557